Slate Medicines’ antibody drug is designed to block PACAP, a protein associated with migraines. The Phase 1-ready asset was licensed from China-based DartsBio Pharmaceuticals.
The post Headache Startup Slate Medicines Lands $130M to Bring Novel Migraine Drug Into the Clinic appeared first on MedCity News.
Tennessee lawmakers float abortion amendment that would charge mothers with homicide
Two Republican lawmakers in Tennessee are floating an amendment to an abortion bill that would bring homicide charges against expecting mothers who choose to terminate
